BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33130126)

  • 1. Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis.
    Lee CH; Choi Y; Cho H; Bang IH; Hao L; Lee SO; Jeon R; Bae EJ; Park BH
    Biochem Pharmacol; 2021 Jan; 183():114312. PubMed ID: 33130126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
    Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
    PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis.
    Chen PJ; Huang C; Meng XM; Li J
    Biochimie; 2015 Sep; 116():61-9. PubMed ID: 26116886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
    Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
    Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
    Abd El Motteleb DM; Ibrahim IAAE; Elshazly SM
    Toxicol Appl Pharmacol; 2017 Nov; 335():64-71. PubMed ID: 28974454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effect of
    Bae UJ; Park BH; Cho MK; Bae EJ
    J Med Food; 2022 Jun; 25(6):652-659. PubMed ID: 35708629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
    Wang Y; Zhao L; Jiao FZ; Zhang WB; Chen Q; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):423-429. PubMed ID: 30249543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
    Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
    Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of class I histone deacetylases attenuate thioacetamide-induced liver fibrosis in mice by suppressing hepatic type 2 inflammation.
    Loh Z; Fitzsimmons RL; Reid RC; Ramnath D; Clouston A; Gupta PK; Irvine KM; Powell EE; Schroder K; Stow JL; Sweet MJ; Fairlie DP; Iyer A
    Br J Pharmacol; 2019 Oct; 176(19):3775-3790. PubMed ID: 31236923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromium attenuates hepatic damage in a rat model of chronic cholestasis.
    Chen WY; Chen CJ; Liao JW; Mao FC
    Life Sci; 2009 Apr; 84(17-18):606-14. PubMed ID: 26324991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERRγ suppression by Sirt6 alleviates cholestatic liver injury and fibrosis.
    Hao L; Bang IH; Wang J; Mao Y; Yang JD; Na SY; Seo JK; Choi HS; Bae EJ; Park BH
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32701506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestasis-Associated Pulmonary Inflammation, Oxidative Stress, and Tissue Fibrosis: The Protective Role of the Biogenic Amine Agmatine.
    Ommati MM; Niknahad H; Najibi A; Arjmand A; Alidaee S; Mazloomi S; Ahmadi P; Ghiasvand A; Javadi M; Yazdani J; Sabouri S; Rezaei H; Azarpira N; Heidari R
    Pharmacology; 2023; 108(4):379-393. PubMed ID: 37253339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury.
    Chan CC; Cheng LY; Lin CL; Huang YH; Lin HC; Lee FY
    Mol Nutr Food Res; 2011 Dec; 55(12):1841-9. PubMed ID: 22086758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Ommati MM; Abdoli N; Aghaei F; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Jan; 97():1086-1095. PubMed ID: 29136945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
    Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
    Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.